Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Karine Tawagi

GU Oncology · UIC

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View

Dr. William Gradishar

Breast Oncology · NU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    PMDr. Pavlos Msaouel
    Leading Voice

    Dr. Pavlos Msaouel

    Hematology & Oncology · Genitourinary Oncology
    The University of Texas MD Anderson Cancer Center
    pavlos

    Research

    The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer

    2026

    Via The Lancet Oncology

    Research

    Duration and Timing of Adjuvant Tyrosine Kinase Inhibitor Therapy in Localized Renal Cell Carcinoma: A Multi-institutional Analysis From the ICICLE-Registry

    2025

    Via The Journal of Urology

    Research

    Perioperative and anesthetic outcomes in patients undergoing nephrectomy for advanced kidney cancer

    2025

    Via The Oncologist

    Research

    Bayesian interim analysis and efficiency of phase III randomized trials

    2025

    Via British Journal of Cancer

    Research

    Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank

    2025

    Via Urologic Oncology

    Research

    Temporal Trends and Socioeconomic Determinants of Cytoreductive Nephrectomy Utilization for Metastatic Renal Cell Carcinoma in the USA

    2025

    Via European Urology Focus

    Research

    Patient, Physician, and Assessor Blinding in Phase III Randomized Trials in Oncology: A Meta-Epidemiological Analysis

    2025

    Via Cancer Medicine

    Research

    Interpreting statistical evidence with S values

    2025

    Via Anaesthesia

    Research

    Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial

    2025

    Via The Lancet Oncology

    Research

    Case Report: Successful delivery following chemotherapy in a pregnant patient with metastatic SMARCB1-deficient renal medullary carcinoma

    2025

    Via Frontiers in Oncology

    Research

    Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study

    2025

    Via Cancer Medicine

    Research

    Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study

    2025

    Via The Oncologist

    Research

    Rethinking End Points in Modern Oncology Trials-Beyond the P Value-Reply

    2025

    Via JAMA Oncology

    Research

    Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling

    2025

    Via Cell Reports Medicine

    Research

    Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy

    2025

    Via JCO Oncology Practice